Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 38.514B	--
--	2025/Q1	-- / 34.641B	--
Feb 10, 2025	2024/Q4	51.141B / 52.583B	--
Nov 8, 2024	2024/Q3	41.323B / 44.248B	--
Aug 8, 2024	2024/Q2	36.651B / 38.356B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 38.514B--

--2025/Q1-- / 34.641B--

Feb 10, 20252024/Q451.141B / 52.583B--

Nov 8, 20242024/Q341.323B / 44.248B--

Aug 8, 20242024/Q236.651B / 38.356B--

Unlock Free Earnings Estimates

Open Account

Kobayashi Pharmaceutical Earnings Reports

Kobayashi Pharmaceutical: Revised Extraordinary Report

Feb 10 01:32 ET

Kobayashi Pharmaceutical: Notice regarding the recording of extraordinary losses and differences between full-year consolidated earnings forecasts and actual results

Feb 10 01:30 ET

Kobayashi Pharmaceutical: Summary of financial results for the fiscal year ending 2024/12 [Japanese GAAP] (consolidated)

Feb 10 01:30 ET

Kobayashi Pharmaceutical: Extraordinary Report

Jan 21 03:01 ET

4967 Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kobayashi Pharmaceutical Q4 2024 Earnings Date

Kobayashi Pharmaceutical Earnings Estimates

Kobayashi Pharmaceutical Earnings Reports

Trending Stocks